Projects per year
Fingerprint
Dive into the research topics where Thomas A. Ullman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Finished
-
-
Preventing Neoplastic Progression in Ulcerative Colitis
National Institute of Diabetes and Digestive and Kidney Diseases
9/15/05 → 8/31/10
Project: Research project
-
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology
Syal, G., Sparrow, M. P., Velayos, F., Cheifetz, A. S., Devlin, S., Irving, P. M., Kaplan, G. G., Raffals, L. E., Ullman, T., Gecse, K. B., Fleshner, P. R., Lightner, A. L., Siegel, C. A. & Melmed, G. Y., Oct 2022, In: Digestive Diseases and Sciences. 67, 10, p. 4687-4694 8 p.Research output: Contribution to journal › Article › peer-review
-
A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities
BRIDGe UC Progression Summit Collaborators, Dec 2022, In: Gastroenterology. 163, 6, p. 1505-1509 5 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance
Mahmoud, R., Shah, S. C., Torres, J., Castaneda, D., Glass, J., Elman, J., Kumar, A., Axelrad, J., Harpaz, N., Ullman, T., Colombel, J. F., Oldenburg, B. & Itzkowitz, S. H., Jun 2020, In: Clinical Gastroenterology and Hepatology. 18, 7, p. 1518-1527.e3Research output: Contribution to journal › Article › peer-review
16 Scopus citations -
Risk of Colon Cancer and Recommended Surveillance Strategies in Patients with Ulcerative Colitis
Rabbenou, W. & Ullman, T. A., Dec 2020, In: Gastroenterology clinics of North America. 49, 4, p. 791-807 17 p.Research output: Contribution to journal › Review article › peer-review
13 Scopus citations -
Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes
Ungaro, R. C., Limketkai, B. N., Jensen, C. B., Yzet, C., Allin, K. H., Agrawal, M., Ullman, T., Burisch, J., Jess, T. & Colombel, J. F., May 2020, In: Clinical Gastroenterology and Hepatology. 18, 5, p. 1152-1160.e1Research output: Contribution to journal › Article › peer-review
12 Scopus citations